BOSTON, October 25, 2024 – Proskauer, a leading international law firm, announced today that it advised ARCH Venture Partners (“ARCH”) on the closing of ARCH Venture Fund XIII. The fund closed with more than $3 billion in commitments and will support the founding and growth of early-stage biotechnology companies.
ARCH founds and invests in groundbreaking life science and technology companies that prevent, detect and cure disease. The firm is a recognized leader in commercializing technologies developed at academic institutions, corporate research groups and national laboratories.
Proskauer has advised ARCH on several previous fund formations as part of its long-standing relationship with the firm, which dates back over 30 years. Most recently, the Firm advised on ARCH Venture Fund XII, which closed in June 2022 with $2.975 billion in commitments.
The Proskauer team was led by partners Robin Painter, David Jones and Jeremy Naylor, senior counsel Louis Sorgi and associates Tracy Rizk, Celeste Kim and Ben Swiszcz (Private Investment Funds).
About Proskauer
The world’s leading organizations and global players choose Proskauer to represent them when they need it the most. With 800+ lawyers in key financial centers around the world, we are known for our pragmatic and commercial approach. Proskauer is the place to turn when a matter is complex, innovative and game-changing. We work seamlessly across practices, industries and jurisdictions with asset managers, private equity and venture capital firms, Fortune 500 and FTSE companies, major sports leagues, entertainment industry legends and other industry-redefining companies.
Proskauer offers a full suite of services for the investment management industry, with a market-leading global team dedicated solely to advising investment funds, including private equity, venture, credit, hedge, real assets and secondaries funds as well as other asset managers, financial institutions, and institutional investors across all asset classes. The cross-border team of over 240 lawyers is based in the U.S., UK and Latin America and includes specialists in fund formation, secondaries transactions and liquidity solutions, tax, ERISA, regulation, financial services, capital markets, M&A, employment, insurance, fund finance, litigation and risk management who understand the unique technical and commercial issues relevant to investment managers.